Status:
RECRUITING
NAD+ Oral Supplement Pilot Intervention in Adult Females
Lead Sponsor:
University of Rhode Island
Collaborating Sponsors:
National Institute of General Medical Sciences (NIGMS)
Conditions:
Cognitive Change
Inflammation
Eligibility:
FEMALE
40-80 years
Phase:
NA
Brief Summary
The goal of this clinical trial is to learn if Nicotinamide adenine dinucleotide (NAD+) can influence cognition and biomarkers in healthy, cognitively intact women who identify as Latina and are betwe...
Eligibility Criteria
Inclusion
- Identify as Latina, have three or more adverse childhood experiences, and a BMI of 18.5 or above
Exclusion
- Those who are taking hormone medication, pregnant or breastfeeding
Key Trial Info
Start Date :
December 1 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 1 2025
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT06579209
Start Date
December 1 2024
End Date
September 1 2025
Last Update
June 12 2025
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Rhode Island
Kingston, Rhode Island, United States, 02881
2
Independence Square, University of Rhode Island
Pawtucket, Rhode Island, United States, 02860